Avzivi 400 mg/16mL
bevacizumab-tnjn · INJECTION, SOLUTION · Bio-Thera Solutions, Ltd.
No Recall History
Plain English
Avzivi is a injection, solution containing bevacizumab-tnjn at 400 mg/16mL, taken intravenous. Manufactured by Bio-Thera Solutions, Ltd..
Key Facts
- Brand Name
- Avzivi
- Generic Name
- bevacizumab-tnjn
- NDC Code (Product)
82143-002- Manufacturer
- Bio-Thera Solutions, Ltd.
- Strength
- 400 mg/16mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761198
- Marketing Start
- 01/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Avzivi used for?
Avzivi contains bevacizumab-tnjn. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Avzivi a controlled substance?
Avzivi is not classified as a controlled substance by the DEA.
What is the generic name for Avzivi?
The generic name for Avzivi is bevacizumab-tnjn. There are no other listed brand versions of bevacizumab-tnjn.
What is the NDC code for Avzivi 400 mg/16mL?
The NDC (National Drug Code) for Avzivi 400 mg/16mL is 82143-002, listed by Bio-Thera Solutions, Ltd..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)